Skip to content
lumos-diagnostics-logo-white-1

LUMOS DIAGNOSTICS · COLD AND FLU TRACKER

Cold & Flu Season Tracker

Where flu and other respiratory illnesses stand in every state this week, based on an analysis of CDC and Epic Research data, updated every Monday.

Source: CDC and Epic Research. Epic Research data may lag CDC reporting by 1–2 weeks. Data are not provided by Lumos Diagnostics.

KEY TAKEAWAY

Loading this week’s data…

OVERALL RESPIRATORY ILLNESS · CDC RESPIRATORY ILLNESSES DATA CHANNEL

Overall respiratory illness

Source: CDC Respiratory Illnesses Data Channel

FLU · CDC FLUVIEW + EPIC RESEARCH

Flu this week

Sources: CDC FluView + Epic Research

OTHER ILLNESSES GOING AROUND · EPIC RESEARCH

Other illnesses going around

Source: Epic Research

FREE WEEKLY REPORTS

ACUTE RESPIRATORY INFECTIONS

Help Rule Out Bacterial Infection in Minutes* with a 99% NPV1

Take a new approach to cold and flu season with FebriDx®, an instrument-free, CLIA-waived fingerstick test.

It delivers clear, objective results that support diagnoses and helps improve communication with patients during respiratory visits.

Learn more about FebriDx →

99% Negative Predictive Value (NPV)

for bacterial infection1

Results in Minutes*

from a simple 5 µL fingerstick1

Instrument-Free

No additional equipment required

Reimbursement Code

PLA code 0442U2

MxA + CRP

dual-biomarker technology3

*Do not read results after 1 hour or before ten minutes.

  1. U.S. Instructions for Use (IFU). Available at lumosdiagnostics.com.
  2. Centers for Medicare & Medicaid Services (CMS). Clinical Laboratory Fee Schedule (CLFS), CY 2026 Q3 Release (26CLABQ3), HCPCS/PLA Code 0442U. Updated July 2026.
  3. Shapiro NI, Self WH, Rosen J, et al. A prospective, multi-centre US clinical trial to determine accuracy of FebriDx point-of-care testing for acute upper respiratory infections with and without a confirmed fever. Ann Med. 2018;50(5):420-9.

Get Ready for Cold & Flu Season with FebriDx®

Tell us where you are in the evaluation process, so we can help you move forward.

Your information is secure and will not be shared. View our Privacy Policy.

Methodology & Data Sources

This tracker uses CDC and Epic Research data to show national and state-level flu and broader respiratory illness trends. Flu-specific measures and overall respiratory activity are shown separately. State and local reports may differ in measures and reporting periods. Data are preliminary and subject to revision.

CDC Respiratory Illnesses Data Channel

Respiratory illness level. The share of emergency department visits for acute respiratory illness, from colds to COVID-19, flu and RSV, compared with each state’s low-season baseline and grouped into five levels. Source: NSSP; dataset.

Wastewater. How much COVID-19, flu A and RSV virus is detected in community wastewater, from very low to very high. Hatching marks data covering less than 5% of a state’s population; flu A results can’t separate human from animal sources or flu A subtypes. Methods. 

Epidemic trends. Whether infections are growing or declining, based on Rt estimated from emergency department visits; not estimated where data are too limited. Source: CDC Center for Forecasting and Outbreak Analytics; dataset. 

CDC FluView

Outpatient flu-like illness (ILINet). The share of outpatient visits for fever plus cough or sore throat, reported weekly by about 4,000 health care providers. State levels (1–13) compare this week’s visits with each state’s level during weeks with little flu: minimal (1–3), low (4–5), moderate (6–7), high (8–10), very high (11–13). ILINet counts symptoms, not lab-confirmed flu, so it can include other respiratory viruses, and it reflects intensity rather than geographic spread. 

Flu lab, hospital and severity data. Test positivity from clinical laboratories; virus types and subtypes from public health laboratories; new hospital admissions reported by all acute care hospitals (NHSN); cumulative hospitalization rates from FluSurv-NET (about 10% of the U.S. population); and pediatric deaths, which may be reported weeks after they occur. Surveillance methods. 

Epic Research

Data are sourced from Epic Research’s Data Tracker, using Cosmos, a dataset combining electronic health record data from participating healthcare organizations that use Epic. Communicable disease trends reflect recorded diagnoses or positive laboratory results per 100,000 patients receiving care in office, emergency department, or inpatient settings. Rates represent patients receiving care within the dataset rather than the general population. Epic Research updates the tracker every other week. cosmos.epic.com 

For full metric definitions, visit Epic Research’s Communicable Diseases tracker.

For Professional Use Only

© 2026 Lumos Diagnostics. All rights reserved.